NEWRON PHARMACEUT. EO-20 Free Cash Flow Generation Index
NEWRON PHARMACEUT. EO-20 free cash flow generation index. NEWRON PHARMACEUT. EO-20 (NP5) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of €33.32 Million represents 1% of operating cash flow (€33.60 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of NEWRON PHARMACEUT. EO-20 (2012–2025)
Free cash flow generation index of NEWRON PHARMACEUT. EO-20 from 2012 to 2025. Historical FCF Generation Index trend for NEWRON PHARMACEUT. EO-20 across 2 annual periods. See how financially flexible is NEWRON PHARMACEUT. EO-20 to measure the company's free cash flow as a share of total liabilities.
NEWRON PHARMACEUT. EO-20 Free Cash Flow Generation Index by Year (2012–2025)
NEWRON PHARMACEUT. EO-20 free cash flow generation index by year from 2012 to 2025. Year-by-year Free Cash Flow Generation Index for NEWRON PHARMACEUT. EO-20. For the full cash flow conversion analysis, see NEWRON PHARMACEUT. EO-20 operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | €32.52 Million | €32.56 Million | €47.31K | ▲ +0.0% |
| 2012 | 1.00x | €5.81 Million | €5.83 Million | €11.00K | — |